Chronic otitis media with effusion in children with adenoidal hypertrophy: Development of a diagnostic prediction

Yu Wu1, Yuan Jiang2, Yan-Xun Han1

  • 1Department of Otorhinolaryngology, Head and Neck Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, China.

Biomolecules & Biomedicine
|November 19, 2025
PubMed

Insights

This study identifies key risk factors for chronic otitis media with effusion (COME) in children with adenoidal hypertrophy (AH). A new nomogram helps predict COME risk, aiding early diagnosis and intervention for better child development.

Area of Science:

  • Otolaryngology
  • Pediatric Health
  • Medical Diagnostics

Background:

  • Chronic otitis media with effusion (COME) significantly impacts child development.
  • Adenoidal hypertrophy (AH) is a common condition in children, often associated with COME.
  • Accurate risk assessment for COME in children with AH is crucial for timely intervention.

Purpose of the Study:

  • To identify risk factors for COME in children with adenoidal hypertrophy (AH).
  • To develop and validate a clinical prediction nomogram for COME risk in this population.
  • To enhance diagnostic accuracy and aid clinical decision-making.

Main Methods:

  • Retrospective analysis of 311 children with AH diagnosed via lateral nasopharyngeal radiographs.
  • Utilized least absolute shrinkage and selection operator (LASSO) for risk factor identification.
  • Employed Firth's penalized logistic regression and internal validation (bootstrapping) to build and assess the predictive model.

Main Results:

  • Identified young age, vitamin D3 deficiency, degree of AH, and tympanometry results as key risk factors.
  • The predictive nomogram achieved a high C-index of 0.945 (internal validation: 0.934).
  • The model demonstrated good calibration and clinical utility across various risk thresholds.

Conclusions:

  • A validated nomogram incorporating age, vitamin D3 levels, AH degree, and tympanometry effectively predicts COME risk in children with AH.
  • This tool can assist clinicians and families in assessing and managing COME risk.
  • Early identification and intervention can mitigate the adverse effects of COME on child development.